1. Exosomes as versatile nanoscaled biocompartments in cancer therapy and/or resistance

Yalda Rahbar Saadat , Jaleh Barar*

BioImpacts. 2022;12(2): 87-88. doi: 10.34172/bi.2022.24253

PMCID: PMC8905586 PMID: 35411296 Scopus ID: 85127210127

Article

PDF

Full Text

XML

Cited By:

Jaleh Barar (PharmD, Ph.D.) is a Full Professor at the Faculty of Pharmacy, Tabriz University of Medical Sciences. Professor Barar is working on various aspects of pharmaceutical cell biology with particular emphasis on the development of novel drug delivery/targeting systems. Dr Barar is listed among top 1% of world scientists based on ESI ranking system.

Original Article

2. Celastrol overcomes 5-fluorouracil resistance in osteosarcoma cells through p53-mediated apoptotic pathway modulation and P-glycoprotein inhibition: A comprehensive mechanistic study

Mohammad Ebrahimnezhad , Amir Valizadeh* , Bahman Yousefi* , Dariush Shanehbandi

Bioimpacts. 2026;16: 32819 | Published on: 2026 Feb 18. doi: 10.34172/bi.32819

Article

PDF

XML

Cited By:

Submit Your Paper Instructions for Authors Aims and Scope Editorial Board Editorial Policies Publication Ethics Policies Editorial Board Policy Abstracting and Indexing Archive

As a peer-reviewed international open-access journal, BioImpacts publishes articles on basic and translational aspects of pharmaceutical and biomedical sciences.
Acceptance rate (2024): 20%
Publication fee: Free of charge

Indexing/Abstracting Info
PubMed; PubMed Central; Scopus; Science Citation Index Expanded; Google Scholar; SJR; Essential Science Indicators; Embase; EBSCOhost; CAS: DOAJ: SHERPA/RoMEO
Member of
Follower of ICMJE
Permission: Creative Commons